CDHA CAAR

July 12, 2021

CAAR – US National Institutes of Health Funding Opportunities – July 12, 2021

Filed under: Employment/Funding Opportunities — Tags: — admin @ 5:58 pm

A. “PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed),” (PA-21-259, a reissue of PA-20-260, National Institute on Aging, in conjunction with other agencies, application deadline Sept. 5, Jan. 5, and April 5). Note: There are three companion funding announcements (follow the link under “Companion Funding Opportunity”): “PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required),” (PA-21-260); “PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required),” (PA-21-261); and “PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed),” (PA-21-262).

grants.nih.gov/grants/guide/pa-files/PA-21-259.html

B. “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans),” (PAR-21-280, National Institute on Aging, deadline for application March 5, 2022, March 5, 2021). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed),” (PAR-21-281).

grants.nih.gov/grants/guide/pa-files/PAR-21-280.html

C. “Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed),” (RFA-AG-22-022, National Institute on Aging, Letter of Intent due date September 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-022.html

D. “Grants for Early Medical/Surgical Specialists’ Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional),” (RFA-AG-22-027, National Institute on Aging, Letter of Intent Due Data October 2, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-027.html

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress